Avinger (NASDAQ:AVGR) Earns Hold Rating from Analysts at StockNews.com

Investment analysts at StockNews.com assumed coverage on shares of Avinger (NASDAQ:AVGR) in a report released on Monday. The brokerage set a “hold” rating on the medical device company’s stock.

Avinger Stock Up 1.7 %

NASDAQ AVGR opened at $0.95 on Monday. Avinger has a 52 week low of $0.90 and a 52 week high of $9.62. The business has a 50 day moving average price of $1.24 and a 200-day moving average price of $2.26. The company has a market cap of $1.61 million, a price-to-earnings ratio of -0.05 and a beta of 1.17.

Avinger (NASDAQ:AVGR) last announced its quarterly earnings results on Thursday, August 8th. The medical device company reported ($2.82) EPS for the quarter, missing analysts’ consensus estimates of ($0.43) by ($2.39). The business had revenue of $1.85 million for the quarter, compared to analyst estimates of $2.55 million. On average, equities research analysts anticipate that Avinger will post -4.69 earnings per share for the current year.

Hedge Funds Weigh In On Avinger

A hedge fund recently bought a new stake in Avinger stock. Armistice Capital LLC acquired a new position in Avinger, Inc. (NASDAQ:AVGR) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 43,747 shares of the medical device company’s stock, valued at approximately $81,000. Armistice Capital LLC owned about 2.57% of Avinger as of its most recent SEC filing. 18.30% of the stock is owned by institutional investors.

About Avinger

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.